vs

Side-by-side financial comparison of FutureFuel Corp. (FF) and PEDEVCO CORP (PED). Click either name above to swap in a different company.

PEDEVCO CORP is the larger business by last-quarter revenue ($23.1M vs $19.8M, roughly 1.2× FutureFuel Corp.). PEDEVCO CORP runs the higher net margin — -36.8% vs -60.5%, a 23.7% gap on every dollar of revenue. On growth, PEDEVCO CORP posted the faster year-over-year revenue change (118.2% vs -67.7%). Over the past eight quarters, PEDEVCO CORP's revenue compounded faster (68.6% CAGR vs -41.7%).

FutureFuel Corporation is a developer and producer of chemicals and biofuels. It is listed on the New York Stock Exchange, with symbol FF.

PEDEVCO Corp is an independent energy company specializing in the acquisition, exploration, development, and production of oil and natural gas assets. It primarily holds and operates onshore resource properties across continental US basins, serving domestic wholesale, utility, and industrial energy customer segments.

FF vs PED — Head-to-Head

Bigger by revenue
PED
PED
1.2× larger
PED
$23.1M
$19.8M
FF
Growing faster (revenue YoY)
PED
PED
+186.0% gap
PED
118.2%
-67.7%
FF
Higher net margin
PED
PED
23.7% more per $
PED
-36.8%
-60.5%
FF
Faster 2-yr revenue CAGR
PED
PED
Annualised
PED
68.6%
-41.7%
FF

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FF
FF
PED
PED
Revenue
$19.8M
$23.1M
Net Profit
$-12.0M
$-8.5M
Gross Margin
-46.7%
Operating Margin
-62.9%
-21.3%
Net Margin
-60.5%
-36.8%
Revenue YoY
-67.7%
118.2%
Net Profit YoY
-529.4%
-243.5%
EPS (diluted)
$-0.28
$-2.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FF
FF
PED
PED
Q4 25
$19.8M
$23.1M
Q3 25
$22.7M
$7.0M
Q2 25
$35.7M
$7.0M
Q1 25
$17.5M
$8.7M
Q4 24
$61.5M
$10.6M
Q3 24
$51.1M
$9.1M
Q2 24
$72.4M
$11.8M
Q1 24
$58.3M
$8.1M
Net Profit
FF
FF
PED
PED
Q4 25
$-12.0M
$-8.5M
Q3 25
$-9.3M
$-325.0K
Q2 25
$-10.4M
$-1.7M
Q1 25
$-17.6M
$140.0K
Q4 24
$2.8M
$5.9M
Q3 24
$-1.2M
$2.9M
Q2 24
$9.6M
$2.7M
Q1 24
$4.3M
$773.0K
Gross Margin
FF
FF
PED
PED
Q4 25
-46.7%
Q3 25
-30.1%
Q2 25
-24.6%
Q1 25
-83.0%
Q4 24
9.1%
Q3 24
0.7%
Q2 24
12.0%
Q1 24
8.6%
Operating Margin
FF
FF
PED
PED
Q4 25
-62.9%
-21.3%
Q3 25
-42.9%
-12.0%
Q2 25
-33.4%
-32.2%
Q1 25
-107.4%
1.7%
Q4 24
2.6%
-12.9%
Q3 24
-5.6%
31.3%
Q2 24
7.5%
22.3%
Q1 24
3.8%
7.6%
Net Margin
FF
FF
PED
PED
Q4 25
-60.5%
-36.8%
Q3 25
-41.1%
-4.7%
Q2 25
-29.2%
-24.0%
Q1 25
-100.6%
1.6%
Q4 24
4.5%
56.0%
Q3 24
-2.3%
32.2%
Q2 24
13.2%
22.7%
Q1 24
7.4%
9.5%
EPS (diluted)
FF
FF
PED
PED
Q4 25
$-0.28
$-2.23
Q3 25
$-0.21
$0.00
Q2 25
$-0.24
$-0.02
Q1 25
$-0.40
$0.00
Q4 24
$0.06
$2.69
Q3 24
$-0.03
$0.03
Q2 24
$0.22
$0.03
Q1 24
$0.10
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FF
FF
PED
PED
Cash + ST InvestmentsLiquidity on hand
$51.3M
$3.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$154.7M
$207.4M
Total Assets
$192.2M
$375.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FF
FF
PED
PED
Q4 25
$51.3M
$3.2M
Q3 25
$85.6M
$10.9M
Q2 25
$95.2M
$8.5M
Q1 25
$97.1M
$10.4M
Q4 24
$109.5M
$4.0M
Q3 24
$133.4M
$4.6M
Q2 24
$115.1M
$6.1M
Q1 24
$201.1M
$13.3M
Stockholders' Equity
FF
FF
PED
PED
Q4 25
$154.7M
$207.4M
Q3 25
$169.1M
$115.4M
Q2 25
$178.2M
$115.2M
Q1 25
$188.4M
$116.2M
Q4 24
$205.8M
$115.6M
Q3 24
$213.3M
$106.5M
Q2 24
$214.4M
$103.2M
Q1 24
$204.8M
$100.0M
Total Assets
FF
FF
PED
PED
Q4 25
$192.2M
$375.9M
Q3 25
$203.5M
$135.9M
Q2 25
$218.2M
$136.8M
Q1 25
$227.7M
$145.6M
Q4 24
$247.7M
$128.3M
Q3 24
$256.5M
$114.3M
Q2 24
$261.2M
$111.0M
Q1 24
$365.4M
$118.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FF
FF
PED
PED
Operating Cash FlowLast quarter
$-27.4M
$-2.1M
Free Cash FlowOCF − Capex
$-29.9M
FCF MarginFCF / Revenue
-150.5%
Capex IntensityCapex / Revenue
12.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-46.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FF
FF
PED
PED
Q4 25
$-27.4M
$-2.1M
Q3 25
$-1.1M
$7.4M
Q2 25
$5.2M
$-420.0K
Q1 25
$-5.4M
$5.9M
Q4 24
$-16.6M
$4.2M
Q3 24
$25.8M
$8.3M
Q2 24
$27.8M
$4.6M
Q1 24
$-12.2M
$-4.3M
Free Cash Flow
FF
FF
PED
PED
Q4 25
$-29.9M
Q3 25
$-6.5M
Q2 25
$-263.0K
Q1 25
$-9.4M
Q4 24
$-20.7M
Q3 24
$20.5M
Q2 24
$24.8M
Q1 24
$-14.5M
FCF Margin
FF
FF
PED
PED
Q4 25
-150.5%
Q3 25
-28.5%
Q2 25
-0.7%
Q1 25
-53.6%
Q4 24
-33.6%
Q3 24
40.1%
Q2 24
34.3%
Q1 24
-24.9%
Capex Intensity
FF
FF
PED
PED
Q4 25
12.2%
Q3 25
23.5%
Q2 25
15.3%
Q1 25
22.8%
Q4 24
6.6%
Q3 24
10.4%
Q2 24
4.1%
Q1 24
3.9%
Cash Conversion
FF
FF
PED
PED
Q4 25
Q3 25
Q2 25
Q1 25
42.34×
Q4 24
-5.94×
0.71×
Q3 24
2.83×
Q2 24
2.90×
1.71×
Q1 24
-2.82×
-5.56×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FF
FF

Chemicals$18.0M91%
Biofuels$1.8M9%

PED
PED

Segment breakdown not available.

Related Comparisons